CNR1 Antikörper (Internal Region)
-
- Target Alle CNR1 Antikörper anzeigen
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CNR1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Cannabinoid Receptor 1
- Sequenz
- HTSEDGKVQV TRPDQ
- Spezifität
- This antibody is expected to recognise both reported isoforms. Isoform a (NP_057167.2, NP_001153732.1, NP_001153731.1, NP_001153730.1, NP_001153698.1) and isoform b (NP_149421.1).
- Kreuzreaktivität
- Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-HTSEDGKVQVTRPDQ, from the internal region of the protein sequence according to NP_057167.2, NP_001153732.1, NP_001153731.1, NP_001153730.1, NP_001153698.1, NP_149421.1.
- Isotyp
- IgG
- Top Product
- Discover our top product CNR1 Primärantikörper
-
-
- Applikationshinweise
-
Western Blot: Approx 55 kDa (non-glycosylated) and 65 kDa (glycosylated) bands observed in lysates of cell line HeLa (calculated MW of 52.9 kDa according to NP_057167.2,). Both bands were successfully blocked by incubation with the immunizing peptide, Reco
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study." in: BMC pregnancy and childbirth, Vol. 14, pp. 395, (2015) (PubMed).
: "
-
Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study." in: BMC pregnancy and childbirth, Vol. 14, pp. 395, (2015) (PubMed).
-
- Target
- CNR1 (Cannabinoid Receptor 1 (CNR1))
- Andere Bezeichnung
- CNR1 (CNR1 Produkte)
- Synonyme
- CANN6 antikoerper, CB-R antikoerper, CB1 antikoerper, CB1A antikoerper, CB1K5 antikoerper, CB1R antikoerper, CNR antikoerper, SKR6R antikoerper, cnr1-A antikoerper, cannabinoid receptor 1 antikoerper, cannabinoid receptor 1 (brain) antikoerper, cannabinoid receptor 1 (brain) S homeolog antikoerper, CNR1 antikoerper, Cnr1 antikoerper, cnr1 antikoerper, cnr1.S antikoerper
- Hintergrund
- Cannabinoid receptor 1 (brain), CNR1, HGNC:2159, CANN6, CB-R, CB1, CB1A, CB1K5, CNR, central cannabinoid receptor, RP1-23D17.1, CB1R, cannabinoid receptor 1 OTTHUMP00000016838, OTTHUMP00000016839
- Gen-ID
- 1268, 12801, 25248
- NCBI Accession
- NP_057167, NP_001153732, NP_001153731, NP_001153730, NP_001153698, NP_149421
- Pathways
- Feeding Behaviour
-